Learn How Voice-Assistant Technology is Revolutionizing Clinical Trials
Pharma tech organizations are leveraging voice assistants to enable continued patient interaction and engagement, especially during clinical trials.
FREMONT, CA: Pharmaceutical organizations are seeking to implement simplicity and convenience into the process of drug development by leveraging the benefits of pharma tech. The technological revolution has introduced wearable devices and monitoring solutions to streamline medical operations and enhance the patient experience.
The medical wearables have enabled the treatment providers to monitor the patients and gather data about their condition remotely, eliminating the need for patients to visit the clinics. The organizations are also encouraging trial patients to install patient-reported outcome data apps on their smartphones instead of carrying around a second device during the study.
Voice assistant technologies such as Amazon Echo and Google Home are also on the rise. According to a prediction by Gartner, almost 30 percent of the web browsing operations will be done using voice assistants and virtual reality. The forecast is bolstered by the 130 percent increase in the sales of voice-enabled devices in the United States.
Check This Out: Top eClinical Trial Management Companies
The integration of voice assistant technology in the pharmaceutical industry can enhance engagement as well as interaction when compared to the traditional approaches. Most patients will inevitably prefer engaging and straightforward conversations over scrolling and tapping. Also, voice-enabled devices can prove a lifesaver for people not well versed in the functionality of mobile devices.
Organizations can leverage voice assistants to enable continued patient interaction and engagement, especially during trials. Even in areas such as patient training, information gathering, consent, and outcomes, voice assistant technology can be leveraged for more exceptional results.
Several organizations are investing in the development of voice assistant technology for clinical data applications. The research aims to evaluate the capabilities of the voice-enabled platforms in highly regulated environments. The benefits of the technology include its ability to engage with users of different languages with minimum intervention.
Even though the current capabilities of the voice assistant technology do not extend to data gathering and analysis, the development of the voice-enabled applications can enhance patient engagement and contribute to the success of the clinical trial. It can also be leveraged to remind the patients of their upcoming visits, arrange cab services, manage study information, secure trial consent, and create medication details, among other concerns.
By Linda H. Butler, VP of Medical Affairs/CMO/CMIO, Rex...
By Laura Cruz, Global CIO, MDC Partners
By Greg Morrison, SVP & CIO, Cox Enterprises
By Lowell Gilvin, Chief Process Officer, Jabil
By Joe LaFeir, SVP, IS&S (Information Systems & Solutions),...
By Gerri Martin-Flickinger, CIO, Adobe Systems
By Aaron Weis, VP & CIO, Axalta Coating Systems
By Levon Hooks, CIO-Global Corporate Solutions, JLL
By Steve Bein, VP-GIS, Michael Baker International
By Sam Schoelen, Chief Information Technology Officer,...
By Georgios Kyriakopoulos, VP of Equity Research, SunTrust...
By David Sliter, VP & GM of Communications, Media &...
By Julie Stafford, SVP Strategic Consulting, Tangoe
By Dan Adam, CIO, Extreme Networks
By Scott Craig, Vice President of Product Marketing, Lexmark...
By Aaron Gette, CIO, The Bay Club Company
By Dr. Volker G. Hildebrand, Global VP, SAP Hybris
By Meerah Rajavel, CIO, Forcepoint
By Philip Loftus, SVP IT & CIO, SSM Health
By Christy Hartner, SVP, Commerce Bank